MBX Biosciences (MBX) Change in Acquisitions & Divestments (2023 - 2026)

MBX Biosciences (MBX) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $57.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 0.61% year-over-year to $57.5 million; the trailing twelve-month figure through Mar 2026 stood at $268.2 million (up 138.1% YoY), and the FY2025 full-year result was $267.9 million, up 235.89% from the prior year.
• Change in Acquisitions & Divestments fell to $57.5 million in Q1 2026, from $76.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $76.2 million in Q4 2025 to a low of $5.0 million in Q4 2023.
• A 4-year average of $41.0 million and a median of $42.1 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments soared 786.33% in 2025 and grew 0.61% in 2026, its largest moves.
• Tracing MBX's Change in Acquisitions & Divestments over 4 years: stood at $5.0 million in 2023, then jumped by 305.0% to $20.2 million in 2024, then soared by 276.54% to $76.2 million in 2025, then decreased by 24.59% to $57.5 million in 2026.
• Business Quant data shows MBX's Change in Acquisitions & Divestments at $57.5 million in Q1 2026, $76.2 million in Q4 2025, and $61.4 million in Q3 2025.